FOLD earnings: a positive outcome, +8.2%

On May 10, 2022, Amicus Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.2% in the window around the event. It had already run -28.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.